Assignee
OPTIMER PHARMACEUTICALS INC
US·9 granted patents·12 pending applications·123 citations·filing 2003–2014
Top patents by PatentIndex Score
21 records- 0196US7378508B2Polymorphic crystalline forms of tiacumicin BOPTIMER PHARMACEUTICALS INC·Filed 2007·Granted May 27, 2008·29 cites·20 claims
- 0291US8012943B2Antibacterial agentsOPTIMER PHARMACEUTICALS INC·Filed 2009·Granted Sep 6, 2011·15 cites·25 claims
- 0389US8343936B2Antibacterial agentsOPTIMER PHARMACEUTICALS INC·Filed 2011·Granted Jan 1, 2013·10 cites·7 claims
- 0489US7601695B2Antibacterial agentsOPTIMER PHARMACEUTICALS INC·Filed 2004·Granted Oct 13, 2009·34 cites·30 claims
- 0587US7863249B2Macrolide polymorphs, compositions comprising such polymorphs, and methods of use and manufacture thereofOPTIMER PHARMACEUTICALS INC·Filed 2008·Granted Jan 4, 2011·10 cites·17 claims
- 0683US8044030B2Antibiotic macrocycle compounds and methods of manufacture and use thereofOPTIMER PHARMACEUTICALS INC·Filed 2008·Granted Oct 25, 2011·5 cites·20 claims
- 0780US7507564B2Tiacumicin productionOPTIMER PHARMACEUTICALS INC·Filed 2003·Granted Mar 24, 2009·15 cites·10 claims
- 0878US8916527B2Antibiotic macrocycle compounds and methods of manufacture and use thereofOPTIMER PHARMACEUTICALS INC·Filed 2013·Granted Dec 23, 2014·3 cites·12 claims
- 0976US7906489B218-membered macrocycles and analogs thereofOPTIMER PHARMACEUTICALS INC·Filed 2007·Granted Mar 15, 2011·2 cites·14 claims
- 1060US2013252914A1Macrolide Polymorphs, Compositions Comprising Such Polymorphs, and Methods of Use and Manufacture ThereofOPTIMER PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 1158US2007105791A1Method of treating clostridium difficile-associated diarrheaOPTIMER PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 1256US2014296498A1Tiacumicin ProductionOPTIMER PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1356US2013252913A118-Membered Macrocycles and Analogs ThereofOPTIMER PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 1454US2014107054A1Method of treating clostridium difficile-associated diarrheaOPTIMER PHARMACEUTICALS INC·Filed 2012·Application pending·0 cites
- 1551US2009247732A1Synthesis of glycopeptides with superior pharmacokinetic propertiesOPTIMER PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 1651US2015141356A1Treatment of Clostridium Difficile Infection in High Risk PatientsOPTIMER PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1751US2008176927A1Compositions of stable tiacumicinsOPTIMER PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 1847US2007173462A1Treatment of diseases associated with the use of antibioticsOPTIMER PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 1946US2015157653A1Prevention of Clostridium Difficile Infection in High Risk PatientsOPTIMER PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2039US2014315838A1Methods of Treating Recurring Bacterial InfectionOPTIMER PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2139US2013331347A1Treatment of Clostridium Difficile Infection in Patients Undergoing Antibiotic TherapyOPTIMER PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →